News & events

40,000 people urged to sign-up to the largest study of depression and anxiety

Researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London and the National Institute for Health Research (NIHR) BioResource are calling for 40,000 people with depression or anxiety to join the online Genetic Links to Anxiety and Depression (GLAD) Study, funded by the NIHR.

By NIHR Maudsley BRC at 18 Sep 2018

Top mental health trust in England for number of research studies

South London and Maudsley NHS Foundation Trust was the top mental health trust in the country for the number of open studies last year with 101 studies available for patients to participate in. This was up by 14 per cent from 89 studies the previous year. This is according to new figures from the National Institute for Health Research (NIHR).

By NIHR Maudsley BRC at 18 Jul 2018

Unprecedented study identifies 44 genetic risk factors for major depression

A global research project has mapped out the genetic basis of major depression, identifying 44 genetic variants which are risk factors for depression, 30 of which are newly discovered. The study, by the Psychiatric Genomics Consortium and co-led in the UK by King’s College London, is the largest study to-date of genetic risk factors for major depression.

By NIHR Maudsley BRC at 26 Apr 2018

UK Biobank mental health study

Until now, UK Biobank, a health data resource aiming to help scientists discover why some people develop particular diseases and others do not, had limited mental health data to work with. Following 157,366 responses to an online mental health questionnaire (MHQ) developed by researchers from King’s College London, alongside collaborators from across the UK, it now has unparalleled potential for further biomedical research in mental health, dramatically expanding potential research into mental disorders. 

By NIHR Maudsley BRC at 3 Apr 2018

Cannabidiol (CBD) could represent a ‘new class of treatment’ for psychosis

A constituent of cannabis could hold promise as a new class of treatment for psychosis, according to King’s College London research showing significant benefits in a clinical trial.

By NIHR Maudsley BRC at 14 Dec 2017
There are 17 items on 4 pages.